Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

NCT: NCT07523620 · RECRUITING

NCT IDNCT07523620
StatusRECRUITING
Start Date2026-03-31
Completion2028-02-28

Brief Summary

The objective of this clinical investigation is to evaluate the feasibility, safety, and effectiveness of a concomitant procedure involving the Volt PFA System and Amulet 2 device in patients indicated for both AF ablation and percutaneous LAAO.

Frequently Asked Questions

What is Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration?

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration is a clinical trial registered under NCT07523620. Current status: RECRUITING.

What is the status of NCT07523620?

The current status of NCT07523620 (Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration) is: RECRUITING.

When did Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration start?

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration started on 2026-03-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑